Product logins

Find logins to all Clarivate products below.


chevron_left

Oncology Drugs to Watch: ASCO 2025 Highlights

Clarivate’s oncology analysts bring you concise, strategic takeaways from this year’s ASCO event – covering key clinical developments, trial readouts, and implications for the future of cancer treatment.

What’s inside the report:

  • Insights on 13 global oncology drugs tracked by Clarivate
  • Late-phase clinical data highlights and trial outcomes
  • Commercial and strategic implications from this year’s ASCO Annual Meeting
  • Analyst perspectives on what’s next for each therapy

Download the report to get the latest insights.

Related insights

The latest news, technologies, and resources from our team.

Cardiovascular medical device market Cardiovascular medical device market
Cardiovascular medical device market
United States Peripheral Bioresorbable Stent United States Peripheral Bioresorbable Stent
United States Peripheral Bioresorbable Stent
Akebia Therapeutics finally scores FDA approval for renal anemia drug vadadustat
chevron_left
chevron_right